This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Hybridon, Inc., Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2000-2026.
Location History:
- Metairie, LA (US) (2000)
- Tampa, FL (US) (2005)
Company Filing History:
2 out of 98 
1 out of 1 Years Active: 2000-2026
Title: The Innovative Contributions of Jiandong Chen
Introduction
Jiandong Chen is a notable inventor based in Tampa, FL, who has made significant contributions to the field of cancer research. With a total of 3 patents to his name, his work focuses on developing innovative therapeutic methods to combat cancer.
Latest Patents
Among his latest patents, the "Merged scaffold TAF1 inhibitors" stands out. This invention discloses inhibitors for TAF1 and methods for using these compounds to treat cancer. Another significant patent is the "MDM2-specific antisense oligonucleotides." This invention provides methods to activate tumor suppressors and includes antisense oligonucleotides that are complementary to a portion of the MDM2-encoding RNA. These oligonucleotides can be used as analytical and diagnostic tools, potentiators of transgenic animal studies, and for gene therapy approaches. Furthermore, the invention outlines methods to augment and synergistically activate a tumor suppressor in conjunction with DNA-damage inducing agents. It also provides in vitro and in vivo models to evaluate the therapeutic effectiveness of a recently identified anti-human-MDM2 antisense oligonucleotide in treating human colorectal cancers.
Career Highlights
Throughout his career, Jiandong Chen has worked with prominent organizations such as Hybridon, Inc. and the Moffitt Cancer Center and Research Institute. His experience in these institutions has allowed him to advance his research and contribute to significant developments in cancer treatment.
Collaborations
Jiandong has collaborated with esteemed colleagues, including Sudhir Agrawal and Ruiwen Zhang. These partnerships have further enriched his research endeavors and have led to innovative solutions in the field of oncology.
Conclusion
Jiandong Chen's contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches continue to pave the way for new therapeutic strategies in the fight against cancer.